Cargando…
Profile of retinal vasculitis in a tertiary eye care center in Eastern India
AIMS: To provide a fact file on the etiology, clinical presentations and management of retinal vasculitis in Eastern India. MATERIALS AND METHODS: Retrospective, record based analysis of retinal vasculitis cases in a tertiary care center in Eastern India from January 2007 to December 2009. RESULTS:...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129755/ https://www.ncbi.nlm.nih.gov/pubmed/21666315 http://dx.doi.org/10.4103/0301-4738.81998 |
_version_ | 1782207557141528576 |
---|---|
author | Saurabh, Kumar Das, Radha R Biswas, Jyotirmay Kumar, Amitabh |
author_facet | Saurabh, Kumar Das, Radha R Biswas, Jyotirmay Kumar, Amitabh |
author_sort | Saurabh, Kumar |
collection | PubMed |
description | AIMS: To provide a fact file on the etiology, clinical presentations and management of retinal vasculitis in Eastern India. MATERIALS AND METHODS: Retrospective, record based analysis of retinal vasculitis cases in a tertiary care center in Eastern India from January 2007 to December 2009. RESULTS: One hundred and thirteen eyes of 70 patients of retinal vasculitis were included in this study. Sixty (85.7%) patients were male (mean age 33± 11.1 years) and 10 (14.3%) were female (mean age 32.4 ± 13.6 years). Vasculitis was bilateral in 43 (61.4%) and unilateral in 27 (38.6%) patients. Commonest symptoms were dimness of vision (73; 64.6%) and floaters (36; 31.9%). Vascular sheathing (82; 72.6%) and vitritis (51; 45.1%) were commonest signs. Mantoux test was positive in 21 (30%) patients but tuberculosis was confirmed in only four (5.71%) patients. Raised serum angiotensin-converting enzyme level and positive antinuclear antibody level were reported in four (5.71%) patients each. Human leukocyte antigen B5 (HLA B5) marker was present in one (1.4%) patient. However, none of the total 70 patients were found to have a conclusively proven systemic disease attributable as the cause of retinal vasculitis. Oral corticosteroid (60; 85.7%) was the mainstay of treatment. Forty-eight (42.5%) eyes maintained their initial visual acuity and 43 (38%) gained one or more line at mean follow-up of 16.6± 6.3 months. CONCLUSION: Retinal vasculitis cases had similar clinical presentations and common treatment plan. There was no systemic disease association with vasculitis warranting a careful approach in prescribing investigations. |
format | Online Article Text |
id | pubmed-3129755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-31297552011-07-11 Profile of retinal vasculitis in a tertiary eye care center in Eastern India Saurabh, Kumar Das, Radha R Biswas, Jyotirmay Kumar, Amitabh Indian J Ophthalmol Original Article AIMS: To provide a fact file on the etiology, clinical presentations and management of retinal vasculitis in Eastern India. MATERIALS AND METHODS: Retrospective, record based analysis of retinal vasculitis cases in a tertiary care center in Eastern India from January 2007 to December 2009. RESULTS: One hundred and thirteen eyes of 70 patients of retinal vasculitis were included in this study. Sixty (85.7%) patients were male (mean age 33± 11.1 years) and 10 (14.3%) were female (mean age 32.4 ± 13.6 years). Vasculitis was bilateral in 43 (61.4%) and unilateral in 27 (38.6%) patients. Commonest symptoms were dimness of vision (73; 64.6%) and floaters (36; 31.9%). Vascular sheathing (82; 72.6%) and vitritis (51; 45.1%) were commonest signs. Mantoux test was positive in 21 (30%) patients but tuberculosis was confirmed in only four (5.71%) patients. Raised serum angiotensin-converting enzyme level and positive antinuclear antibody level were reported in four (5.71%) patients each. Human leukocyte antigen B5 (HLA B5) marker was present in one (1.4%) patient. However, none of the total 70 patients were found to have a conclusively proven systemic disease attributable as the cause of retinal vasculitis. Oral corticosteroid (60; 85.7%) was the mainstay of treatment. Forty-eight (42.5%) eyes maintained their initial visual acuity and 43 (38%) gained one or more line at mean follow-up of 16.6± 6.3 months. CONCLUSION: Retinal vasculitis cases had similar clinical presentations and common treatment plan. There was no systemic disease association with vasculitis warranting a careful approach in prescribing investigations. Medknow Publications 2011 /pmc/articles/PMC3129755/ /pubmed/21666315 http://dx.doi.org/10.4103/0301-4738.81998 Text en © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Saurabh, Kumar Das, Radha R Biswas, Jyotirmay Kumar, Amitabh Profile of retinal vasculitis in a tertiary eye care center in Eastern India |
title | Profile of retinal vasculitis in a tertiary eye care center in Eastern India |
title_full | Profile of retinal vasculitis in a tertiary eye care center in Eastern India |
title_fullStr | Profile of retinal vasculitis in a tertiary eye care center in Eastern India |
title_full_unstemmed | Profile of retinal vasculitis in a tertiary eye care center in Eastern India |
title_short | Profile of retinal vasculitis in a tertiary eye care center in Eastern India |
title_sort | profile of retinal vasculitis in a tertiary eye care center in eastern india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129755/ https://www.ncbi.nlm.nih.gov/pubmed/21666315 http://dx.doi.org/10.4103/0301-4738.81998 |
work_keys_str_mv | AT saurabhkumar profileofretinalvasculitisinatertiaryeyecarecenterineasternindia AT dasradhar profileofretinalvasculitisinatertiaryeyecarecenterineasternindia AT biswasjyotirmay profileofretinalvasculitisinatertiaryeyecarecenterineasternindia AT kumaramitabh profileofretinalvasculitisinatertiaryeyecarecenterineasternindia |